Supernus Pharmaceuticals Price to Book Ratio 2011-2024 | SUPN
Historical price to book ratio values for Supernus Pharmaceuticals (SUPN) over the last 10 years. The current price to book ratio for Supernus Pharmaceuticals as of November 20, 2024 is 1.95.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Supernus Pharmaceuticals Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-11-19 |
35.53 |
|
1.95 |
| 2024-09-30 |
31.18 |
$18.24 |
1.71 |
| 2024-06-30 |
26.75 |
$17.39 |
1.54 |
| 2024-03-31 |
34.11 |
$16.98 |
2.01 |
| 2023-12-31 |
28.94 |
$16.84 |
1.72 |
| 2023-09-30 |
27.57 |
$16.81 |
1.64 |
| 2023-06-30 |
30.06 |
$16.85 |
1.78 |
| 2023-03-31 |
36.23 |
$16.81 |
2.15 |
| 2022-12-31 |
35.67 |
$16.33 |
2.18 |
| 2022-09-30 |
33.85 |
$16.01 |
2.11 |
| 2022-06-30 |
28.92 |
$15.80 |
1.83 |
| 2022-03-31 |
32.32 |
$15.56 |
2.08 |
| 2021-12-31 |
29.16 |
$15.32 |
1.90 |
| 2021-09-30 |
26.67 |
$15.33 |
1.74 |
| 2021-06-30 |
30.79 |
$14.78 |
2.08 |
| 2021-03-31 |
26.18 |
$14.24 |
1.84 |
| 2020-12-31 |
25.16 |
$14.09 |
1.79 |
| 2020-09-30 |
20.84 |
$13.46 |
1.55 |
| 2020-06-30 |
23.75 |
$12.66 |
1.88 |
| 2020-03-31 |
17.99 |
$11.68 |
1.54 |
| 2019-12-31 |
23.72 |
$11.33 |
2.09 |
| 2019-09-30 |
27.48 |
$10.62 |
2.59 |
| 2019-06-30 |
33.09 |
$9.97 |
3.32 |
| 2019-03-31 |
35.04 |
$9.17 |
3.82 |
| 2018-12-31 |
33.22 |
$8.66 |
3.84 |
| 2018-09-30 |
50.35 |
$8.07 |
6.24 |
| 2018-06-30 |
59.85 |
$7.48 |
8.00 |
| 2018-03-31 |
45.80 |
$6.81 |
6.72 |
| 2017-12-31 |
39.85 |
$5.21 |
7.65 |
| 2017-09-30 |
40.00 |
$4.91 |
8.15 |
| 2017-06-30 |
43.10 |
$4.52 |
9.53 |
| 2017-03-31 |
31.30 |
$4.10 |
7.63 |
| 2016-12-31 |
25.25 |
$3.84 |
6.58 |
| 2016-09-30 |
24.73 |
$3.50 |
7.07 |
| 2016-06-30 |
20.37 |
$2.23 |
9.15 |
| 2016-03-31 |
15.25 |
$1.96 |
7.76 |
| 2015-12-31 |
13.44 |
$1.80 |
7.48 |
| 2015-09-30 |
14.03 |
$1.61 |
8.69 |
| 2015-06-30 |
16.98 |
$1.48 |
11.45 |
| 2015-03-31 |
12.09 |
$1.34 |
9.01 |
| 2014-12-31 |
8.30 |
$0.95 |
8.76 |
| 2014-09-30 |
8.69 |
$0.84 |
10.36 |
| 2014-06-30 |
10.95 |
$0.79 |
13.83 |
| 2014-03-31 |
8.94 |
$0.69 |
12.96 |
| 2013-12-31 |
7.54 |
$0.84 |
9.01 |
| 2013-09-30 |
7.33 |
$0.40 |
18.22 |
| 2013-06-30 |
6.43 |
$1.16 |
5.54 |
| 2013-03-31 |
5.62 |
$1.34 |
4.21 |
| 2012-12-31 |
7.17 |
$1.88 |
3.81 |
| 2012-09-30 |
11.55 |
$1.01 |
11.47 |
| 2012-06-30 |
9.36 |
$1.55 |
6.03 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.962B |
$0.608B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
